Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

Clinical trial registration, sponsored by National Institute on Aging (NIA), registered 23 Jul 2026.

Phase 2 · recruiting · n = 200

Tags: Registry, Psilocybin, Neurological.

Weekly Science Digest, 6 Nov 2026 to 12 Nov 2026, finding 6: In the clinic

NIA trial of cognitive training with or without psilocybin in older adults with mild cognitive impairment is listed as recruiting

How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)

Weekly Science Digest, 3 Oct 2026 to 9 Oct 2026, finding 6: In the clinic

NIA's psilocybin-plus-cognitive-training trial in older adults with mild cognitive impairment is recruiting

How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)

Weekly Science Digest, 20 Jul 2026 to 2 Oct 2026, finding 11: 20 new trials registered

New registrations include psilocybin for methamphetamine use disorder, borderline personality disorder, nicotine craving and premenstrual dysphoric disorder, and a National Institute on Aging trial pairing psilocybin with cognitive training. Results were posted for psilocybin in depression and anxiety in Parkinson's disease.

How much weight it carries: Registrations show what is being attempted, not what was found. (Registry, Plans, not results)

Read the original

—
Node—
Statuslive
Throughput—